Anzeige
Meldung des Tages: Lettland-Defence-Zertifikat! Diese Aktie öffnet die Tür zu bis zu 3 Mio. € Finanzierung

Haemonetics Aktie News

Aktie
WKN:  881782 ISIN:  US4050241003 US-Symbol:  HAE Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  USA
61,19 $
+0,52 $
+0,86%
51,938 € 20.02.26
Depot/Watchlist
Marktkapitalisierung *
3,19 Mrd. €
Streubesitz
-
KGV
18,05
Dividende
0,25 $
Dividendenrendite
0,21%
Index-Zuordnung
-

Haemonetics News

20.02.26 - PR Newswire
Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference
Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference PR Newswire
05.02.26 - PR Newswire
Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website
Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website PR Newswire
09.01.26 - PR Newswire
Haemonetics Acquires Vivasure Medical Limited
Haemonetics Acquires Vivasure Medical Limited PR Newswire
09.01.26 - PR Newswire
Haemonetics Acquires Vivasure Medical Limited
Haemonetics Acquires Vivasure Medical Limited PR Newswire
07.01.26 - PR Newswire
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2026 Results: February 5, 2026
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2026 Results: February 5, 2026 PR Newswire
02.01.26 - PR Newswire
Haemonetics to Present at 44th Annual J.P. Morgan Healthcare Conference
Haemonetics to Present at 44th Annual J.P. Morgan Healthcare Conference PR Newswire
06.11.25 - PR Newswire
Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website
Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website PR Newswire
09.10.25 - PR Newswire
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2026 Results: November 6, 2025
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2026 Results: November 6, 2025 PR Newswire
07.08.25 - PR Newswire
Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website
Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website PR Newswire
09.07.25 - PR Newswire
Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2026 Results: August 7, 2025
Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2026 Results: August 7, 2025 PR Newswire
30.05.25 - PR Newswire
Haemonetics to Present at Goldman Sachs 46th Annual Global Healthcare Conference
Haemonetics to Present at Goldman Sachs 46th Annual Global Healthcare Conference PR Newswire
08.05.25 - PR Newswire
Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website
Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website PR Newswire
31.03.25 - PR Newswire
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2025 Results: May 8, 2025
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2025 Results: May 8, 2025 PR Newswire
03.03.25 - PR Newswire
Haemonetics Announces Executive Leadership Updates
Haemonetics Announces Executive Leadership Updates PR Newswire

Newssuche

Videos

newspaper
18.02.26 -2,76%
Technical Trading: Chance mit 82 Prozent Treffern
Rohöl Long Typ: Turbo Open End WKN: VH65XQ Hebel:6 Laufzeit: OpenEnd Einstieg: Market ... Mehr »